Nanomedicine for T‐Cell Mediated Immunotherapy (Adv. Mater. 22/2024)

Nanomedicine Nanomedicines, with their diverse, flexible, and intelligent features, can enhance T cell‐based therapy for various diseases. The article number 2301770 by Weisheng Guo, Xing‐Jie Liang, and co‐workers focuses on T‐cell immunotherapy and how nanotechnology can improve its efficacy and sa...

Full description

Saved in:
Bibliographic Details
Published in:Advanced materials (Weinheim) 2024-05, Vol.36 (22), p.n/a
Main Authors: Li, Fangzhou, Ouyang, Jiang, Chen, Zuqin, Zhou, Ziran, Milon Essola, Julien, Ali, Barkat, Wu, Xinyue, Zhu, Mengliang, Guo, Weisheng, Liang, Xing‐Jie
Format: Article
Language:English
Subjects:
autoimmune diseases
biomimetic materials
cancer
immunotherapy
Lymphocytes
nanomedicines
T cells
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Nanomedicine Nanomedicines, with their diverse, flexible, and intelligent features, can enhance T cell‐based therapy for various diseases. The article number 2301770 by Weisheng Guo, Xing‐Jie Liang, and co‐workers focuses on T‐cell immunotherapy and how nanotechnology can improve its efficacy and safety, provides a deeper understanding of the mechanisms and challenges involved in using nanomedicines to augment T‐cell mediated immunotherapy.
ISSN:0935-9648
1521-4095
DOI:10.1002/adma.202470166